Antipsychotics in child and adolescent patients with major depressive disorder: A retrospective analysis of prescribing patterns

• Главные авторы: Danielle Dauchot, PharmD (Автор), Suzanne Rettey, PharmD, MPA, BCPP (Автор), Brittany L. Melton, PharmD, PhD (Автор), Karen E. Moeller, PharmD, BCPP (Автор)
• Формат: ‌
• Опубликовано: American Association of Psychiatric Pharmacists, 2024-02-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Introduction Depression rates in children/adolescents in the United States have increased in the last 10 years. Fluoxetine and escitalopram are the only 2 antidepressants approved for the treatment of major depression disorder (MDD) in children/adolescents. In adults, some antipsychotics are approve...